Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.

Dysregulation of oncogenes by translocation to an IgH (14q32) or IgL (kappa, 2p11 or lambda, 22q11) locus is a frequent event in the pathogenesis of B-cell tumors. Translocations involving an IgH locus and a diverse but nonrandom array of chromosomal loci occur in most multiple myeloma (MM) tumors even though the translocations often are not detected by conventional cytogenetic analysis. In a continuing analysis of translocations in 21 MM lines, we show that the novel, karyotypically silent t(14;16)(q32.3;q23) translocation is present in 5 MM lines, with cloned breakpoints from 4 lines dispersed over an approximately 500-kb region centromeric to the c-maf proto-oncogene at 16q23. Another line has a t(16;22)(q23;q11), with the breakpoint telomeric to c-maf, so that the translocation breakpoints in these 6 lines bracket c-maf. Only these 6 lines overexpress c-maf mRNA. As predicted for dysregulation of c-maf by translocation, there is selective expression of one c-maf allele in 2 informative lines with translocations. This is the first human tumor in which the basic zipper c-maf transcription factor is shown to function as an oncogene.

[1]  G. Kelsoe,et al.  V(D)J recombinase activity in a subset of germinal center B lymphocytes. , 1997, Science.

[2]  B. Klein,et al.  Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma , 1997, Nature Genetics.

[3]  M. Taniwaki,et al.  The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. , 1997, Blood.

[4]  E. Schröck,et al.  Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 , 1997, Nature Genetics.

[5]  E. Schuuring,et al.  The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene. , 1997, Blood.

[6]  P. L. Bergsagel,et al.  Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  E. Schuuring,et al.  Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. , 1996, Blood.

[8]  D. Gerhard,et al.  Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. , 1996, Blood.

[9]  Cécile Fizames,et al.  A comprehensive genetic map of the human genome based on 5,264 microsatellites , 1996, Nature.

[10]  B. Barlogie,et al.  Cytogenetic findings in 200 patients with multiple myeloma. , 1995, Cancer genetics and cytogenetics.

[11]  J. Mary,et al.  Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. , 1995, Blood.

[12]  B. Klein,et al.  Interleukin-6 in human multiple myeloma. , 1995, Blood.

[13]  C. Kurschner,et al.  The maf proto-oncogene stimulates transcription from multiple sites in a promoter that directs Purkinje neuron-specific gene expression , 1995, Molecular and cellular biology.

[14]  W. Kuehl,et al.  Genes expressed selectively in murine and human plasma cell neoplasms. , 1995, Current topics in microbiology and immunology.

[15]  M. Taniwaki,et al.  Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. , 1994, Blood.

[16]  M. Seto,et al.  A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. , 1994, Blood.

[17]  M. Jourdan,et al.  Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. , 1994, Blood.

[18]  K. Kataoka,et al.  Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family , 1993, Journal of virology.

[19]  S. Korsmeyer,et al.  Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. , 1992, Annual review of immunology.

[20]  J. Trent,et al.  Development and characterization of a melphalan-resistant human multiple myeloma cell line. , 1991, Cancer research.

[21]  P. Sherrington,et al.  A new human plasma cell line, Karpas 620, with translocations involving chromosomes 1, 11 and 14 , 1990, British journal of haematology.

[22]  K. Kataoka,et al.  v-maf, a viral oncogene that encodes a "leucine zipper" motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Longo,et al.  Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[24]  M. Boccadoro,et al.  The human myeloma cell line LP-1: a versatile model in which to study early plasma-cell differentiation and c-myc activation. , 1989, Blood.

[25]  S. Latt,et al.  A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) burkitt lymphoma , 1984, Cell.